Heteromer formation between cannabinoid type 1 and dopamine type 2 receptors is altered by combination cannabinoid and antipsychotic treatments

Amina M. Bagher, Alexander P. Young, Robert B. Laprairie, James T. Toguri, Melanie E.M. Kelly, Eileen M. Denovan-Wright

Research output: Contribution to journal › Article › peer-review

12 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Heteromer formation between cannabinoid type 1 and dopamine type 2 receptors is altered by combination cannabinoid and antipsychotic treatments'. Together they form a unique fingerprint.

Neuroscience

Keyphrases